Vaidya Sane Ayurved Laboratories Limited — Investor Meet, 10-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Madhavbaug reported strong H1 FY'26 financial results with revenue up 19.48% to 49.94 Cr, EBITDA up 49.59% to 8.62 Cr (17.26% margin), and PAT up 28.26% to 4.84 Cr. Management projects FY'26 revenue of 115-120 Cr, targeting 250 Cr by FY'28. Growth drivers include expanding hospital bed capacity to 350-370 beds and adding 40-50 new clinics. The company is pursuing mainboard listing and expanding internationally with a Malaysia partnership. Confident outlook is driven by increasing patient footfall and a focus on disease reversal.